A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine to shorten treatment in #TB patients.
#Archivel Farma has designed and set up a phase IIb clinical study called CONSTAN-ARG to explore whether administering the RUTI® vaccine for patients with pulmonary #tuberculosis (TB) can shorten the current antibiotic treatment. The study has been approved in September by the Argentine Regulatory Agency of Medicines (ANMAT). The main site is located in the Hospital Lencinas de Mendoza, and the first patient is expected to be recruited in October 2022.